4th Annual COMPANION DIAGNOSTICS FORUM Precision Medicine without Borders
October 29-30, 2019 New Jersey Hospital Association Princeton, NJ
Join us at the 4th Annual Companion Diagnostics Conference in Princeton. Precision Medicine has surpassed its original vision directed to genomics and cancer and now encompasses a host of diagnostic and therapeutic modalities. In the time since the formal announcement in 2015, drugs and assays have been developed based on a broader array of pathways and targets. Precision Medicine has also expanded beyond the geographic borders of the original targeted market regions to new countries, each with its own market needs and regulations.
What has driven this expansion? What challenges are presented? At this Forum, we explore how Precision Medicine has been taken up across geographic borders, expanded to include new therapeutic areas, and broadened to develop novel drugs and assay types. Of particular interest for the Forum are the challenges of bringing precision medicine to international markets – for example, how lessons learned within country can be applied (or not!) to other countries.
Talk Recordings from the previous Companion Diagnostics Forums are available to view, you will just need to fill in a simple form to view. Call for Abstracts is now Open.
Compelling reasons to attend this year’s Forum:
Wide range of high quality attendees and speakers from key Pharmas and Biotechs, Life Science Suppliers and more
Comfortable size (capped at 225 Attendees) and configuration designed to encourage networking
Free full video recordings from previous events – get an idea of the event, topics covered, speaker styles.
Attendee Pricing 75% less below other CDx and Biomarker events. Special discounted pricing to Pharmas and Biotechs to encourage broad participation of key R&D attendees in discussions
Located near research and development facilities of key Companion Diagnostic Pharmas to encourage their broad participation and ability to meet T&L restrictions. Cross-promotion at internal Company events that PlanetConnect manages.
New topics on the promotion and uptake of Precision Dx and Rx
Special Panels including:
Clinical and Regulatory Experts in Precision Medicine including “Ask me Anything! (on Precision Medicine)” session
Diagnostics Accuracy and Innovation Act – Implementation and Impact
Targeted audience: Those Developing and Launching Precision Diagnostics and Therapeutics in global and domestic markets
Vice Presidents, Executive/Senior Directors, Senior Scientists in related fields including Licensing and Regulatory
Laboratory and Technology Directors
Project Managers to manage international collaborations (technical, logistical, and transitioning projects to partners)
Technology leaders and researchers – precision tools, processes, platforms, informatics
Researchers in precision assays, diagnostics (basic, development, validation, execution)
Researchers in novel precision therapeutics – vaccines, biologics, and small molecules
“Overall, the conference was fantastic. The quality of talks was outstanding: Michelle, Nick, Steve, Jeff, Bill, Ken, Chris Major, etc, etc Their talks were great. I really like that vendors like Nanostring and ThermoFisher gave great talks explaining the development of their approved CDx and outcome of FDA review, plus tough situations they encountered during this process. Fantastic meeting!”
Oscar Puig Chief Scientific OfficerPhosphorus
Register 3 Attendees to the Companion Diagnostics Conference, get one free Attendee pass for your Company.